CPIX - cumberlandpharma.com Company Buyout Price

Brandmark of Cumberland Corp (CPIX)

This daily price chart for Cumberland Pharmaceuticals (CPIX) reflects a business valuation of 73.49. Cumberland Pharmaceuticals (CPIX) maintains high credibility within US clinics due to its production of life-saving medications. Growth is driven by the active acquisition of approved products for the hospital sector, while stability is ensured by modern facilities with upgraded equipment that eliminates any production disruptions.

cumberlandpharma.com (CPIX) - Total Company Value from 11/23/2025 to 10/29/2026
Brand item of Cumberland Pharmaceuticals

Enterprise Value (EV) determines the total acquisition cost of an asset by summing market capitalization and net debt. For Cumberland Pharmaceuticals (CPIX), this calculation is critical for optimizing distribution and managing free cash flow. By analyzing the current EV, an investor assesses the real value of the business beyond just the shares. This metric allows for the identification of company undervaluation during the portfolio scaling phase. The stability of this indicator confirms the holding's financial resilience.

Competitors of Cumberland Pharmaceuticals (CPIX)

HLN (Haleon PLC) - Full Business Value|Kenvue Corp - Enterprise Value|Company Buyout Price Verona Pharma Inc. VRNA|MENS (Jyong Biotech Ltd) - Real Price to Acquire Entire Company|Business Value LGND|Total Company Value Amneal|Perrigo Company PLC - Full Business Value|Enterprise Value ALVO|LQDA (Liquidia Inc.) - Value Adjusted for Debt and Cash|Enterprise Value GLPG (Galapagos NV)|Enterprise Value anipharmaceuticals.com ANIP|MNKD - Total Company Value|Value Adjusted for Debt and Cash AMPH (Amphastar Pharmaceuticals Inc)|Pacira (PCRX) - Total Company Value|Real Price to Acquire Entire Company ARS Corp|TBPH (Theravance Biopharma) - Enterprise Value|Enterprise Value aquestive.com|Real Price to Acquire Entire Company SCPH (scPharmaceuticals Inc.)|TECX (tectonictx.com) - Value Adjusted for Debt and Cash|Total Company Value Tonix Pharmaceuticals Inc. TNXP|SXT Pharmaceuticals (SXTC) - Total Enterprise Value|EPRX: Real Price to Acquire Entire Company|bioharvest.com - Aggregate Business Value|EXOZ: Enterprise Value|Oramed Pharmaceuticals Inc. - Value Adjusted for Debt and Cash|ENTX (Entera Bio Ltd) - Enterprise Value|Total Enterprise Value MindWalk Therapeutics HYFT|Total Company Value ABVC BioPharma (ABVC)|QNTM (quantumbiopharma.com) - Value Adjusted for Debt and Cash|Enterprise Value FGEN (FibroGen)|TELO - Real Price to Acquire Entire Company|RANI: Real Price to Acquire Entire Company|SNYR - Enterprise Value|rallybio.com (RLYB) - Total Company Value|Real Price to Acquire Entire Company Lexaria Bioscience Corp.|PULM (Pulmatrix) - Enterprise Value|Total Company Value PTHL|Enterprise Value APM|LYRA - Total Enterprise Value|Total Company Value Impact BioMedical IBO|Value Adjusted for Debt and Cash TNFA|YCBD - Total Company Value|PRFX: Total Company Value|CYTO: Enterprise Value|Lipella Pharma (LIPO) - Enterprise Value|Total Company Value OptiNose, Inc.|Business Value PIRS (pieris.com)|Enterprise Value PROC|Petros Pharmaceuticals Inc - Business Value|Qilian International Holding Group Limited - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash SLRN|TFFP - Total Company Value